Fundraising FoxBlade Therapeutics
South San Francisco, US · Founded 2015 · Delaware corporation · 6 known investors
Find your way into Blade Therapeutics
Sign up to see every warm intro you have to Blade Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Blade Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
WR
Wendye RobbinsPresident and Chief Executive Officer (formerly Interim CEO)2015–2022Wendye Robbins is an executive officer and director at Blade Therapeutics, which develops treatments for untreatable diseases. With background in life sciences entrepreneurship, she has worked in translational medicine and team building.
Board
LE
CW
PV
EJ
Elaine JonesBoard director
WS
William SlatteryBoard director
JS
James ScopaBoard director
Investors · 6
OUP (Osage University Partners)listed by OUP (Osage University Partners)Bala Cynwyd · $1M – $20M
How we know: OUP (Osage University Partners)'s portfolio page · Not right? Tell us
Pfizer Venture Investmentslisted by Pfizer Venture Investments$5M – $20M
How we know: Pfizer Venture Investments's portfolio page · funding news · Not right? Tell us
+ND CapitalinferredWoodside · $540K – $5.4Mvia Peter Van Vlasselaer · board
How we know: board seat on SEC Form D · Not right? Tell us
Deerfield Management CompanyreportedNew York
How we know: funding news · Not right? Tell us
MPM BioImpactreportedBoston · $1M – $15Mvia Luke Evnin · board
How we know: board seat on SEC Form D · funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$77M disclosed across 3 of 4 rounds · 2016–2019
- Undisclosed amountSeries BOct 2017Source ↗
▶$12MraisedOct 2019 · 21 investors · BiotechnologyRule 506(b)
▶$12MraisedOct 2019 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Prabha IbrahimExecutive Officer
- William V. SlatteryDirector
- James ScopaDirector
- Gary PatouExecutive Officer
- Lloyd B. KlicksteinDirector
- Cameron WheelerDirector
- Peter Van VlasselaerDirector
- Luke EvninDirector
- Wendye Rae RobbinsExecutive Officer, Director
- Rana Al-HallaqDirector
- M. Shirley ChiangExecutive Officer
- Offering amount
- $24M
- Amount sold
- $12M
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$38MraisedOct 2019 · 10 investors · BiotechnologyRule 506(b)
▶$38MraisedOct 2019 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rana Al-HallaqDirector
- Wendye Rae RobbinsExecutive Officer, Director
- William V. SlatteryDirector
- James ScopaDirector
- Gary PatouExecutive Officer
- Lloyd B. KlicksteinDirector
- Prabha IbrahimExecutive Officer
- M. Shirley ChiangExecutive Officer
- Cameron WheelerDirector
- Peter Van VlasselaerDirector
- Luke EvninDirector
- Offering amount
- $50M
- Amount sold
- $38M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$27.1MraisedJun 2016 · 10 investors · BiotechnologyRule 506(b)
▶$27.1MraisedJun 2016 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Luke EvninDirector
- Cameron WheelerDirector
- Peter van VlasselaerDirector
- Elaine JonesDirector
- Wendye RobbinsExecutive Officer, Director
- William SlatteryDirector
- James ScopaDirector
- Offering amount
- $45.4M
- Amount sold
- $27.1M
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Blade Therapeutics went on to found or lead other companies.
Frequently asked questions
- Who are Blade Therapeutics's investors?
- Blade Therapeutics's investors include Bay City Capital, OUP (Osage University Partners), Pfizer Venture Investments, +ND Capital, Deerfield Management Company, MPM BioImpact.
- How much funding has Blade Therapeutics raised?
- Blade Therapeutics has disclosed $77M raised across 3 of its 4 known rounds.
- Where is Blade Therapeutics headquartered?
- Blade Therapeutics is headquartered in South San Francisco, US.